Displaying 1 - 50 of 74 results
Released Company Title Industry Topic
28 Mar 2024
07:00 CET
EUROAPI SA Document d’Enregistrement Universel 2023 20103015 Pharmaceuticals Other subject
28 Mar 2024
07:00 CET
EUROAPI SA 2023 Universal Registration Document 20103015 Pharmaceuticals Other subject
14 Mar 2024
18:55 CET
EUROAPI SA Perspectives 2024 suspendues à la suite de l’arrêt temporaire de production d’API sur le site de Brindisi en Italie 20103015 Pharmaceuticals Other subject
14 Mar 2024
18:55 CET
EUROAPI SA Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy 20103015 Pharmaceuticals Other subject
28 Feb 2024
19:16 CET
EUROAPI SA Résultats annuels 2023 20103015 Pharmaceuticals Other subject
28 Feb 2024
19:16 CET
EUROAPI SA Full-year 2023 results 20103015 Pharmaceuticals Other subject
25 Jan 2024
07:00 CET
EUROAPI SA EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO) 20103015 Pharmaceuticals Other subject
25 Jan 2024
07:00 CET
EUROAPI SA EUROAPI enrichit ses compétences en CDMO grâce à une collaboration essentielle avec SpiroChem, une Contract Research Organization (CRO) de premier plan 20103015 Pharmaceuticals Other subject
04 Jan 2024
17:45 CET
EUROAPI SA EUROAPI renforce son Comité Exécutif en nommant Ludwig de Mot Directeur Général Adjoint, en charge de la transformation de l’entreprise 20103015 Pharmaceuticals Other subject
04 Jan 2024
17:45 CET
EUROAPI SA EUROAPI Strengthens its Executive Committee with the Appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer 20103015 Pharmaceuticals Other subject
28 Nov 2023
08:00 CET
EUROAPI SA EUROAPI Appoints New Executive Committee Members 20103015 Pharmaceuticals Other subject
28 Nov 2023
08:00 CET
EUROAPI SA EUROAPI nomme de nouveaux membres au Comité Exécutif 20103015 Pharmaceuticals Other subject
21 Nov 2023
17:45 CET
EUROAPI SA CDMO : EUROAPI finalise l’acquisition de Biano 20103015 Pharmaceuticals Other subject
21 Nov 2023
17:45 CET
EUROAPI SA CDMO: EUROAPI Completes Acquisition of Biano 20103015 Pharmaceuticals Other subject
30 Oct 2023
18:38 CET
EUROAPI SA EUROAPI: Information Relating to the Financial Terms of the Departure of the Chief Executive Officer and the Appointment of the Chairman of the Board as Interim Chief Executive Officer 20103015 Pharmaceuticals Other subject
30 Oct 2023
18:38 CET
EUROAPI SA EUROAPI : Information relative aux conditions financières du départ du Directeur Général et de la nomination de la Présidente du Conseil d’Administration comme Directrice Générale par intérim 20103015 Pharmaceuticals Other subject
25 Oct 2023
18:15 CEST
EUROAPI SA Nouvelle gouvernance chez EUROAPI 20103015 Pharmaceuticals Other subject
25 Oct 2023
18:15 CEST
EUROAPI SA EUROAPI Announces New Governance 20103015 Pharmaceuticals Other subject
24 Oct 2023
17:45 CEST
EUROAPI SA EUROAPI Increases the Resources Allocated to the Liquidity Contract With Kepler Cheuvreux 20103015 Pharmaceuticals Other subject
24 Oct 2023
17:45 CEST
EUROAPI SA EUROAPI : Augmentation des moyens affectés au contrat de liquidité conclu avec Kepler Cheuvreux 20103015 Pharmaceuticals Other subject
09 Oct 2023
17:45 CEST
EUROAPI SA EUROAPI: Full-Year 2023 Outlook Revised Downwards 20103015 Pharmaceuticals Other subject
09 Oct 2023
17:45 CEST
EUROAPI SA EUROAPI : Objectifs 2023 revus à la baisse 20103015 Pharmaceuticals Other subject
29 Aug 2023
07:00 CEST
EUROAPI SA EUROAPI to Acquire BianoGMP to Strengthen its CDMO Expertise in the High-Growth oligonucleotide Market 20103015 Pharmaceuticals Other subject
29 Aug 2023
07:00 CEST
EUROAPI SA EUROAPI va acquérir BianoGMP pour renforcer son expertise CDMO sur le marché en forte croissance des oligonucléotides 20103015 Pharmaceuticals Other subject
02 Aug 2023
17:45 CEST
EUROAPI SA EUROAPI : Mise à disposition du Rapport financier semestriel 2023 20103015 Pharmaceuticals Corporate life
02 Aug 2023
17:45 CEST
EUROAPI SA EUROAPI: Availability of 2023 Half-Year Financial Report 20103015 Pharmaceuticals Corporate life
01 Aug 2023
07:00 CEST
EUROAPI SA EUROAPI: H1 2023 RESULTS 20103015 Pharmaceuticals Other subject
01 Aug 2023
07:00 CEST
EUROAPI SA EUROAPI : RESULTATS SEMESTRIELS 2023 20103015 Pharmaceuticals Other subject
13 Jun 2023
13:55 CEST
EUROAPI SA Health Sovereignty: EUROAPI Supports the Supply of Essential Medicines to France and Europe 20103015 Pharmaceuticals Other subject
13 Jun 2023
13:55 CEST
EUROAPI SA Souveraineté sanitaire : EUROAPI se mobilise en faveur de l’approvisionnement de la France et de l’Europe en médicaments essentiels 20103015 Pharmaceuticals Other subject
06 Jun 2023
17:45 CEST
EUROAPI SA EUROAPI to Invest €50 Million at Its Budapest Site to Meet the Growing Demand for Prostaglandins 20103015 Pharmaceuticals Other subject
06 Jun 2023
17:45 CEST
EUROAPI SA EUROAPI va investir 50 millions d’euros sur son site de Budapest pour répondre à la demande croissante de prostaglandines 20103015 Pharmaceuticals Other subject
11 May 2023
18:00 CEST
EUROAPI SA EUROAPI : Assemblée Générale Mixte du 11 mai 2023 20103015 Pharmaceuticals Other subject
11 May 2023
18:00 CEST
EUROAPI SA EUROAPI: Combined General Meeting of May 11, 2023 20103015 Pharmaceuticals Other subject
10 May 2023
20:18 CEST
EUROAPI SA EUROAPI’s Board of Directors Proposes Géraldine Leveau as Director 20103015 Pharmaceuticals Other subject
10 May 2023
20:18 CEST
EUROAPI SA Le Conseil d’administration d’EUROAPI propose Géraldine Leveau en tant qu’administrateur 20103015 Pharmaceuticals Other subject
09 May 2023
07:00 CEST
EUROAPI SA EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects 20103015 Pharmaceuticals Other subject
09 May 2023
07:00 CEST
EUROAPI SA EUROAPI et Novéal signent un accord de CDMO pour des projets dans le domaine de la cosmétique 20103015 Pharmaceuticals Other subject
26 Apr 2023
18:00 CEST
EUROAPI SA EUROAPI: Availability of the Amendment n°1 of the 2022 Universal Registration Document 20103015 Pharmaceuticals Other subject
26 Apr 2023
18:00 CEST
EUROAPI SA EUROAPI : Mise à disposition de l’Amendement n°1 du Document d’Enregistrement Universel 2022 20103015 Pharmaceuticals Other subject
14 Apr 2023
23:00 CEST
EUROAPI SA EUROAPI: Availability of the 2022 Universal Registration Document, Including the Annual Financial Report 20103015 Pharmaceuticals Other subject
14 Apr 2023
23:00 CEST
EUROAPI SA EUROAPI : Mise à disposition du Document d’Enregistrement Universel 2022, contenant le Rapport Financier Annuel 20103015 Pharmaceuticals Other subject
08 Mar 2023
07:00 CET
EUROAPI SA EUROAPI: Full-Year 2022 Results 20103015 Pharmaceuticals Other subject
08 Mar 2023
07:00 CET
EUROAPI SA EUROAPI : RESULTATS ANNUELS 2022 20103015 Pharmaceuticals Other subject
31 Jan 2023
07:00 CET
EUROAPI SA EUROAPI: Progressive restart of prostaglandin production at Budapest site 20103015 Pharmaceuticals Other subject
31 Jan 2023
07:00 CET
EUROAPI SA EUROAPI : Redémarrage progressif de la production de prostaglandines sur le site de Budapest 20103015 Pharmaceuticals Other subject
11 Jan 2023
18:00 CET
EUROAPI SA EUROAPI’s Board of Directors Proposes Mattias Perjos as Independent Director 20103015 Pharmaceuticals Other subject
11 Jan 2023
18:00 CET
EUROAPI SA Le Conseil d’administration d’EUROAPI propose Mattias Perjos en tant qu’administrateur indépendant 20103015 Pharmaceuticals Other subject
09 Jan 2023
07:00 CET
EUROAPI SA Vitamine B12 : EUROAPI va investir 40 millions d’euros dans un procédé de production plus efficace et durable en France 20103015 Pharmaceuticals Other subject
09 Jan 2023
07:00 CET
EUROAPI SA Vitamin B12: EUROAPI to Invest €40 Million for a More Efficient and Sustainable Production Process in France 20103015 Pharmaceuticals Other subject